A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan(CKD-828) Versus S-Amlodipine Monotherapy in Patients With Stage 2 Hypertension

Trial Profile

A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan(CKD-828) Versus S-Amlodipine Monotherapy in Patients With Stage 2 Hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Jan 2016

At a glance

  • Drugs Levamlodipine/telmisartan (Primary) ; Levamlodipine
  • Indications Hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea).
    • 26 Jul 2012 Status changed from not yet recruiting to recruiting as reported by Korean Clinical Trials Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top